Back to Archived Journals » Open Access Insect Physiology » Volume 4

Transcription profiling of guanine nucleotide binding proteins during developmental regulation and pesticide response in Solenopsis invicta (Hymenoptera: Formicidae)

Authors Zhao L, Chen, Jones

Received 29 June 2012

Accepted for publication 6 August 2012

Published 8 October 2012 Volume 2012:4 Pages 31—39


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Liming Zhao, Jian Chen, Walker A Jones

Biological Control of Pests Research Unit, National Biological Control Laboratory, Mid South Area, Agricultural Research Service, United States Department of Agriculture, Stoneville, MS, USA

Abstract: Guanine nucleotide binding proteins (GNBP), glycoproteins anchored on the cytoplasmic cell membrane, are mediators for many cellular processes. Complete cDNA of the GNBP gene β-subunit (SiGNBP) was cloned and sequenced from Solenopsis invicta Buren (Hymenoptera: Formicidae) worker ants. To understand whether SiGNBP is developmentally regulated in S. invicta, its expression levels in different developmental stages were examined using quantitative real-time polymerase chain reaction. SiGNBP was expressed in each developmental stage, and was especially highly expressed in the late larval and early pupal stages, as well among the dealate females (queens) ~10 days post nuptial flight. Quantitative real-time polymerase chain reaction also showed that mRNA transcription levels of SiGNBP in S. invicta workers were regulated during the duration of the study in response to heat shock, ultraviolet light, and boric acid treatment. These results suggest that the SiGNBP gene may play an important role in the development of S. invicta, and this has potential for use as a target in new insecticides for the control of fire ants.

Keywords: Solenopsis invicta, guanine nucleotide binding proteins, development, boric acid, mRNA transcription

Creative Commons License © 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.